During the past decade, Yale U / New Haven Med Ctr / AIDS Clinical Trials Unit conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yale U / New Haven Med Ctr / AIDS Clinical Trials Unit" are "HIV Infections" (3 trials). Many other conditions were trialed in "Yale U / New Haven Med Ctr / AIDS Clinical Trials Unit" in a lesser frequency.

Most popular intervention types in "Yale U / New Haven Med Ctr / AIDS Clinical Trials Unit" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abacavir sulfate" (1 trials), "Amprenavir" (1 trials), "Indinavir sulfate" (1 trials), "Nelfinavir mesylate" (1 trials) and "Ritonavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale U / New Haven Med Ctr / AIDS Clinical Trials Unit" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Yale U / New Haven Med Ctr / AIDS Clinical Trials Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Yale U / New Haven Med Ctr / AIDS Clinical Trials Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yale U / New Haven Med Ctr / AIDS Clinical Trials Unit, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".